AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG)

Top Analyst Upgrades and Downgrades: AMAG, Foot Locker, Groupon, H&R Block, McDonald’s, Teradata, Under Armour, Valeant and More

Stocks were indicated marginally lower on Monday morning, with more worries of trade wars after steel and aluminum tariffs. The Dow Jones industrial average was indicated to open under 24,500 and ...
Read Full Story »

Why AMAG Pharmaceuticals Is Soaring

AMAG Pharmaceuticals Inc. (NASDAQ: AMAG) saw its shares skyrocket early on Thursday after the company announced that it received an FDA approval. Specifically, the company said that the FDA approved ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AMAG, Baidu, Cisco, GE, Honeywell, 3M, Salesforce, SunPower, UTC and More

This week has been a wild ride, but it has been a week full of recovery in stocks versus last week's panic selling with broken market efficiencies. The bull market ...
Read Full Story »

Top Stocks to Look For in February’s FDA Calendar

Companies that reside within the biotech and pharmaceutical industries are subject to a sizable amount of risk with regards to their drug candidates passing clinical trials and gaining regulatory approval. ...
Read Full Story »
Female patient on gurney

Why Amag Pharmaceuticals Is Sinking Despite Positive Top-Line Results

AMAG Pharmaceuticals Inc. (NASDAQ: AMAG) saw its shares take a sharp turn down after the company reported top-line results from its most recent pharmacokinetic (PK) study. The results were ultimately ...
Read Full Story »
buy sell stocks

Top Analyst Upgrades and Downgrades: Amex, Goldman Sachs, Illumina, PayPal, Trivago, Williams Companies and More

Stocks have yet to hit the sentimental Dow 20,000 mark, and futures were indicated lower on Tuesday. The post-election rally has continued and investors are looking for value and growth ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Abercrombie, Altria, Anthem, United Continental, Blackstone, AMAG Pharma and More

Stocks hit all-time highs at the end of 2016, and they have been looking for direction after a gap-up did not really hold on the first day of 2017. With ...
Read Full Story »
Test tubes

Biotech Is the Cheapest Since 2011: 4 Top Stocks to Buy Now

In an almost incredible turn of events due to the massive selling among the biotechs, the four largest companies in the industry on a price-to-earnings multiple basis are actually cheaper ...
Read Full Story »
buy sell

Top Analyst Upgrades and Downgrades: GE, 3M, Shopify, SunPower, Zafgen, CIT, Ericsson, Honeywell and Many More

Stocks were looking for a small bounce on Thursday after Wednesday's big sell-off that ended up being less of a big sell-off. Investors have every right to feel jilted in ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades from Monday: AMAG, Nike, Cempra, Discovery, HCI Group and More

Stocks were indicated lower on Monday, but this is expected to be a thin volume post-Christmas session. It seems like stocks want to follow oil lower, and the stock market ...
Read Full Story »
Test tubes

4 Biopharma and Pharmaceutical Stocks With Game-Changing Catalysts Coming

Needless to say, the biopharmaceutical and pharmaceutical sectors are probably the most susceptible to binary and headline catalysts than any other in the investing world, because so often the catalysts ...
Read Full Story »
buy sell

15 Fresh Analyst Stock Picks Called to Rise 50% to 100%

This past week may have been painful for the markets with a 665 point drop in the Dow as the rate hike probability gets ever more realistic. Many key stocks ...
Read Full Story »
buy sell

Top Analyst Upgrades and Downgrades: AMAG, Devon Energy, eBay, Freshpet, Range Resources, Raytheon, SeaWorld, Zynga and More

Stocks were indicated lower on Thursday, but this week has shown yet again that investors will keep buying sell-offs. 24/7 Wall St. reviews dozens of analyst research reports each day ...
Read Full Story »
buy now

Jefferies Has 4 Very Bold Value Calls This Week

As we start to close in on the end of the year, with just seven trading weeks left in 2015, many investors are staring at portfolio statistics that are discouraging. ...
Read Full Story »
buy now

Jefferies Has Very Compelling Value Stocks to Buy Now

Anyway you look at it, the market is starting to get pricey. With a huge rally off the second low that matched the late August sell-off, the S&P 500 is ...
Read Full Story »